To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions

NCT00861939 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: Bupropion HCI 300 mg Extended-Release Tablets EON
DRUG: WELLBUTRIN XL 300 mg Extended-Release Tablets GlaxoSmithKline

Sponsor

Sandoz